Phathom Pharmaceuticals Inc Live Stock Price Today, Share Analysis and Chart

Name: Phathom Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Phathom Pharmaceuticals Inc
Rating: 2.10975
Author: Trendlyne DVM scores

about

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule...

12.18 -0.18 (-1.46%)

38.20% Fall from 52W High

600.4K

XNAS Volume

XNAS 29 Aug, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for Phathom Pharmaceuticals Inc is on 08 Sep 2025 for the purpose of H.C. Wainwright 27th Annual Global Investment Conference See details